Skip to content

Comparison of the therapeutic effects of M1 and Bifrontal TDCS in the treatment of patients with shoulder girdle myofascial syndrome.

Comparison of therapeutic effects of M1 and Bifrontal transcranial direct current stimulation montages in treatment of shoulder girdle myofacial syndrome: A randomized clinical trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20081004001292N6
Enrollment
60
Registered
2020-06-06
Start date
2020-05-21
Completion date
Unknown
Last updated
2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Myofascial pain syndrome. Condition 2: Myofascial pain syndrome. Myalgia Chronic pain syndrome

Interventions

Intervention 1: Intervention First group: transcranial direct current stimulation M1 montage. Intervention 2: Intervention Second group: transcranial direct current stimulation Bifrontal montage. Int

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Diagnosis of chronic myofascial pain in the shoulder girdle. A history of at least 3 months of pain due to shoulder girdle myofascial pain syndrome. Spontaneous pain in at least one of the trigger points in the trapezius, supraspinatus, rhomboid, and levator scapulae muscles. Use of stable dose of painkillers, at least 3 months prior to the study. Pain intensity of 5 or greater with VAS criteria over the past week. Age between 18 and 50 years old.

Exclusion criteria

Exclusion criteria: Previous diagnosis of shoulder pathology other than MPS that can help with pain, including partial dislocation, instability, fracture, frozen shoulder, infection and inflammation. Cervical radiculopathy based on clinical examinations. Diagnosis of neurological diseases such as Alzheimer's or Parkinson's. Severe psychological conditions or symptoms such as schizophrenia, major depression or mania. Current pregnancy or lactation. History of seizures. Defects in the skull bone. Existence of skin scar at the electrode installation site. Tumors in the tissue of the areas below the electrode. Current use of herbal remedies or other alternative therapies such as recent topical injections for pain.

Design outcomes

Primary

MeasureTime frame
Pain threshold. Timepoint: Before and immediately after the intervention. Method of measurement: Wagner digital Pain algometer.;Self-Perception of improvement. Timepoint: Before and immediately after the intervention. Method of measurement: Pain Self-Efficacy Questionnaire (PSEQ).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBehzad Izadseresht

Tabriz University of Medical Sciences

b.izadseresht@yahoo.com+98 41 3326 8029

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026